Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report of China Biopharmaceuticals  Holdings, Inc.
(the  "Company"),  on Form 10-K for the period ended  December 31, 2008 as filed
with the  Securities  and  Exchange  Commission  ("SEC") on the date hereof (the
"Report"),  the  undersigned  officer of the Company  certifies,  pursuant to 18
U.S.C.  ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that, to the best of his knowledge:

i. the Report fully complies with the  requirements  of Section 13(a)or 15(d) of
the Securities Exchange Act of 1934; and

ii. the  information  contained in the Report fairly  presents,  in all material
respects, the financial condition and results of operations of the Company.

/s/ Chris Peng Mao
- ------------------

Chris Peng Mao
Chief Executive Officer
March 31, 2009